Navigation Links
Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
Date:7/10/2012

WEST BRIDGEWATER, Mass., July 10, 2012 /PRNewswire/ -- Cardiosolutions, Inc. an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group (Reuters Code: SORN.MI), a global medical device company and an international leader in the treatment of cardiovascular disease.

Cardiosolutions' technology consists of a proprietary catheter delivery system and an implant, the Mitra-Spacer™. This implant is designed to fill the void created by a dilated annulus or deteriorating valve mechanism providing a sealing surface for the leaflets of the mitral valve, thus reducing the degree of mitral regurgitation in patients.

This cutting-edge technology represents a less invasive, percutaneous solution for patients who suffer from moderate to severe mitral regurgitation, including a portion of those who have congestive heart failure. Today two to three percent of the world's population suffers from mitral regurgitation and approximately 2.3 million patients in the US and Europe suffer from severe mitral regurgitation. Every year approximately 500,000 new patients are diagnosed with this disease, of which over 80% are untreated.  A substantial group of patients have no option because they are too sick to survive the surgery and many others delay treatment because they have only moderate symptoms. All these patients could benefit from a less invasive solution.

Sorin's $8 million investment will finance on-going product development and clinical testing of this technology. Under the terms of the agreement, Sorin also has an option to acquire the company in the future. Sorin Group joins STD Med and BioVentures Investors as an investor in Cardiosolutions.

"We are very pleased to have Sorin Group, a leading Global medical device company, as our strategic partner in Cardiosolutions. They bring valuable industry experience, strong competencies in regulatory and clinical studies, as well as a strong marketing and distribution platform as we continue to make advances with our Mitral-Spacer technology. " said Steven Tallarida, President and CEO of Cardiosolutions.

"Mitral valve disease is significantly undertreated in the world today and patients are looking for less invasive therapies to address this problem. The investment in Cardiosolutions confirms Sorin's commitment to continuously introduce innovation in the Heart Valve business and represents an important step forward in our long-term growth initiatives" said Andre-Michel Ballester, CEO of Sorin Group.

About Cardiosolutions, Inc.

Cardiosolutions, Inc. ("Cardiosolutions" or the "Company") www.cardiosolutionsinc.com  is developing a less invasive, percutaneous alternative to open heart surgical repair of the mitral valve. The Cardiosolutions Percu-Pro™ System and Mitra-Spacer™ will provide a long-term therapeutic substitute to this complicated open heart valve repair procedure. In this connection, it will address the unmet clinical need for a minimally invasive solution to the nearly 200,000 patients diagnosed annually with moderate to severe mitral regurgitation who currently forgo treatment because they cannot tolerate a highly invasive procedure. The Company is another novel medical device technology incubated within and spun out of STD Med Inc. (Stoughton MA.) partnering with BioVentures Investors, a leading Medtech venture firm.

About Sorin Group

Sorin Group (www.sorin.com) is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, Sorin Group focuses on three major therapeutic areas: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over one million patients are treated with Sorin Group devices in more than 80 countries.


'/>"/>
SOURCE Cardiosolutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
2. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
3. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
4. Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimers Drug
5. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
6. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
7. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
8. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
9. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
10. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
11. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
(Date:4/27/2016)... , April 27, 2016 ... over USD 2.14 billion by 2022, according to ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ... advancement affecting the efficiency and accuracy delivered by ... persistent demand for novel urinalysis instruments and consumables. ...
(Date:4/26/2016)... CHICAGO , April 26, 2016 Hill-Rom Holdings, ... to a management presentation at the Deutsche Bank 41 st ... at 2:50 p.m. EDT. You are invited to ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas ... one hour after conclusion of the live event and accessible ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online ... cosmetictown.com . The forum section was recently revamped and upgraded to allow even more ... in use across the country. , According to the senior editor of Cosmetic Town, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... has been collaborating with doctors and hospitals to make transformative changes in how ... leading cell therapy minds this week in discussing breakthroughs in cellular medicine to ...
(Date:4/28/2016)... Washington D.C. (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us ... and Prevention (CDC), a stroke is the fourth leading cause of death in the United ... country, with almost a quarter of them in individuals under 65 years old. A ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... M.D. has been named a Top Doc in Physical Medicine and Rehabilitation by ... with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership across ...
(Date:4/28/2016)... ... 2016 , ... Denise McCormick Baich had written poetry dating back to her childhood, but after ... a tsunami and took on a more spiritual tone. The desire to put the words ... with it than just file it away. Friends would ask her how she wrote such ...
Breaking Medicine News(10 mins):